Morgan, Lewis & Bockius acted as legal counsel to Eli Lilly, and Ropes & Gray acted as legal counsel to Sigilon. Eli Lilly and Company (NYSE:...
Eli Lilly’s Acquisition of Sigilon Therapeutics
BDT Capital Partners’ $125 Million Preferred Equity Investment in National Amusements
Ropes & Gray advised National Amusements Inc. on the deal. National Amusements, Inc, the majority voting shareholder of Paramount Global, announced that it has entered into...
Charlesbank Capital Partners’ Acquisition of The Packaging Wholesalers
Ropes & Gray represented Charlesbank Capital Partners LLC and its portfolio company, BOX Partners on the deal. Charlesbank Capital Partners LLC and its portfolio company, BOX...
Charlesbank Capital Partners’ Investment in Salus GRC
Ropes & Gray advised Charlesbank Capital Partners and Salus GRC on the deal. Charlesbank Capital Partners (“Charlesbank”) announced that it has entered into a partnership with...
Marquee Brand’s Acquisition of America’s Test Kitchen
Ropes & Gray represented America’s Test Kitchen Limited Partnership on the deal. Latham & Watkins and Greenberg Traurig represented Marquee Brands. America’s Test Kitchen Limited Partnership...
NEUCA’s Partnership with OncoBay
Pillsbury Winthrop Shaw Pittman LLP advised NEUCA Group on the deal while Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical. NEUCA Group, the parent...
Scipher Medicine’s Acquisition of CrossBridge
Ropes & Gray represented Scipher Medicine on the deal. Precision immunology company Scipher Medicine announced its acquisition of data, analytics and software company CrossBridge to enhance...
Clinscience’s Investment in OncoBay
Ropes & Gray advised Moffitt Cancer Center and OncoBay Clinical on the deal. OncoBay obtained an investment from Clinscience, a global clinical research organization based in Warsaw,...
Xeris Biopharma’s Research Collaboration with Horizon Therapeutics
Ropes & Gray represented Xeris Biopharma on the deal. Xeris Biopharma announced a research collaboration and option agreement with Horizon Therapeutics. Under the agreement announced on November...
Audax Private Equity’s Acquisition of DISA Global Solutions
Ropes & Gray advised Audax Private Equity, while Dechert advised DISA Global Solutions in the deal. Audax Private Equity executed its acquisition of DISA Global Solutions,...
Charlesbank Capital Partners and Motive Partners’ Investment in Accordion Partners
Willkie Farr & Gallagher advised FFL Partners and Accordion, while Ropes & Gray advised Charlesbank and Gibson, Dunn & Crutcher advised Motive on the deal. FFL...
Cullinan Oncology’s Collaboration with Taiho Pharmaceutical
Ropes & Gray represented Cullinan Oncology in the deal. Cullinan Oncology announced a strategic collaboration with Taiho Pharmaceutical under which Taiho will acquire Cullinan Oncology’s subsidiary Cullinan...